Key result
Selective cyclooxygenase-2 (COX-2) inhibitors were evaluated for their association with cardiovascular events in patients treated for arthritis.
Key points are not available for this paper at this time.
Introduction of selective cyclooxygenase (COX)-2 inhibitors held a promise of improved treatment of arthritis without the gastrointestinal effects associated with aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), which effect
No takes yet. Share an insight, caveat, or question.
Pitt et al. (2002) studied this question. Selective cyclooxygenase-2 (COX-2) inhibitors were evaluated for their association with cardiovascular events in patients treated for arthritis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: